Newsroom
Success Stories
More than 80 user projects were successfully launched within our infrastructure at our partner sites in the EU-OPENSCREEN member countries.
In the following, we will highlight in special "sucess stories" the progress of these projects.
Prof. Jan Rybniker
University Hospital Cologne, Germany
Phenotypic screening for novel antibiotics targeting Mycobacterium tuberculosis
Dr Eulàlia de Nadal
IRB Barcelona, Spain
Identifying phosphomimetic RB modulators
Dr Maria J. Macias
IRB Barcelona, Spain
Targeting SMAD4, a transcription factor protein mutated in tumours and rare diseases
Prof. Alessandro Provenzani
University of Trento, Italy
Interfering with RAN translation in ALS – An extensive screening campaign with high-quality laboratory practices
Prof. Emiliano Biasini
University of Trento, Italy
Identification of the Pharmacological Target of Compounds Modulating the Activity of the Cellular Prion Protein (CHEMPRION)
Dr. Marcin Grzybowski
MOLECURE S.A., Poland
By leveraging EU-OPENSCREEN services, Marcin was able to utilise advanced MALDI-MSI technology to visualise the metabolic alterations induced by OATD-02.
Dr. Monika Schmidt
University of Hradec Králové, Czech Republic
Screening of European Chemical Biology Library revealed small molecules which inhibit a mitochondrial enzyme involved in Alzheimer’s disease
Professor Juana Diez
Pompeu Fabra University, Spain
Cooperation between Fabra University in Spain, HZI in Germany and Masaryk University in Czech Republic conducted a screening under BSL3 conditions with exceptional efficiency.
Dr. Félix Torres
ETH Zürich, Laboratory of physical chemistry, Switzerland
Collaboration between ETH Zürich and EU-OPENSCREEN paved the way for ultrafast NMR screening and supported the launch of a promising start-up company
Prof. Ana Garcia Saez
University of Cologne, Institute for Genetics, Germany
Screening of our European Chemical Biology Library (ECBL) uncovered new modulators of Mitochondria-ER contact sites